Why the "SAFE Drugs Act" Isn't Safe for Patients | Essential: The Pharmacy Compounding Podcast
In this episode, Andrew Kantor is joined by federal lobbyist David Pore and PCCA's Amy Shank to examine the proposed SAFE Act and its potential impact on compounding pharmacies. The discussion explores concerns that the bill could restrict patient access to compounded medications during drug shortages, impose new limitations on 503A pharmacies, and disproportionately affect legitimate compounders while failing to address bad actors. The episode also unpacks the legislation's connection to GLP-1 demand, adverse event reporting, and the bipartisan politics surrounding the bill, while encouraging listeners to stay engaged in APC's advocacy efforts.
You May Also Like

Follow the Money
VSiN

Durham News Today | 2 Min News | The Daily News Now!
The Daily News Now!

St. Louis on the Air
St. Louis Public Radio

NPR News Now
NPR

Indisputable with Dr. Rashad Richey
TYT Network

Deadline: White House
Nicolle Wallace, MS NOW

مقالات الرأي
Asharq Al-Awsat / الشرق الأوسط

Anchorage News Today | 2 Min News | The Daily News Now!
The Daily News Now!

Bulwark Takes
The Bulwark
Podcasts von Tichys Einblick
Tichys Einblick
Community discussion